We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.58B
AUM Growth
+$249M
Cap. Flow
+$113M
Cap. Flow %
7.12%
Top 10 Hldgs %
25.66%
Holding
3,941
New
148
Increased
2,113
Reduced
1,207
Closed
172

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Financials 13.46%
3 Consumer Discretionary 8.83%
4 Industrials 8.51%
5 Healthcare 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUE icon
3251
Monte Rosa Therapeutics
GLUE
$1.35B
$361 ﹤0.01%
80
-1,148
-93% -$5.12K
KSPI icon
3252
Kaspi.kz JSC
KSPI
$17.2B
$340 ﹤0.01%
4
-356
-99% -$30.4K
TPIC
3253
DELISTED
TPI Composites
TPIC
$338 ﹤0.01%
393
-2,332
-86% -$2.37K
TNGX icon
3254
Tango Therapeutics
TNGX
$4.41B
$333 ﹤0.01%
+65
New +$161
TSQ icon
3255
Townsquare Media
TSQ
$118M
$324 ﹤0.01%
41
-46
-53% -$325
FVRR icon
3256
Fiverr
FVRR
$339M
$323 ﹤0.01%
11
AOMR
3257
Angel Oak Mortgage REIT
AOMR
$209M
$320 ﹤0.01%
+34
New +$309
SEVN
3258
Seven Hills Realty Trust
SEVN
$174M
$314 ﹤0.01%
26
-26
-50% -$305
IGIC icon
3259
International General Insurance
IGIC
$1.15B
$312 ﹤0.01%
13
CMRC
3260
Commerce.com Inc Series 1
CMRC
$184M
$310 ﹤0.01%
62
-831
-93% -$4.28K
ITRN icon
3261
Ituran Location and Control
ITRN
$1.05B
$310 ﹤0.01%
8
LYEL icon
3262
Lyell Immunopharma
LYEL
$360M
$309 ﹤0.01%
+35
New +$319
ELPC icon
3263
Copel
ELPC
$8.57B
$307 ﹤0.01%
36
DAWN
3264
DELISTED
Day One Biopharmaceuticals
DAWN
$306 ﹤0.01%
47
-236
-83% -$1.62K
HBB icon
3265
Hamilton Beach Brands
HBB
$422M
$304 ﹤0.01%
17
-55
-76% -$976
DON icon
3266
WisdomTree US MidCap Dividend Fund
DON
$4.09B
$301 ﹤0.01%
6
-13
-68% -$628
RDDT icon
3267
Reddit
RDDT
$31.1B
$301 ﹤0.01%
2
HQI icon
3268
HireQuest
HQI
$185M
$300 ﹤0.01%
30
-12
-29% -$123
VNDA icon
3269
Vanda Pharmaceuticals
VNDA
$302M
$297 ﹤0.01%
+63
New +$275
TRAK icon
3270
ReposiTrak
TRAK
$159M
$295 ﹤0.01%
15
-42
-74% -$880
RXRX icon
3271
Recursion Pharmaceuticals
RXRX
$1.73B
$293 ﹤0.01%
58
-7,166
-99% -$35.2K
DLO icon
3272
dLocal
DLO
$4.24B
$272 ﹤0.01%
24
SCLX icon
3273
Scilex Holding
SCLX
$48.9M
$271 ﹤0.01%
+46
New +$260
GLBE icon
3274
Global E Online
GLBE
$7.11B
$268 ﹤0.01%
8
-6
-43% -$202
JBLU icon
3275
JetBlue
JBLU
$2.29B
$254 ﹤0.01%
60
-4,530
-99% -$20.3K

Similar funds

GAMMA Investing's Q2 2025 Portfolio in Review

As of Q2 2025, GAMMA Investing held 3,941 positions worth $1.58B, up 19% from $1.33B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $113M of net new capital in Q2 2025, opening 148 new positions and adding to 2,113 existing holdings. Its largest new stake was iShares iBonds Dec 2029 Term Corporate ETF: 33,844 shares worth $790K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Equity Premium Income ETF, an estimated $5.77M trimmed.

  • GAMMA Investing's largest Q2 2025 buy was iShares iBonds Dec 2029 Term Corporate ETF: 33,844 shares worth $790K.
  • GAMMA Investing added most to Microsoft in Q2 2025, an estimated $13.5M increase.
  • GAMMA Investing's biggest Q2 2025 reduction was JPMorgan Equity Premium Income ETF, cutting an estimated $5.77M.
  • GAMMA Investing fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q2 2025, selling an estimated $5.06M.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.58B portfolio in Q2 2025.
  • GAMMA Investing opened 148 new positions and closed 172 in Q2 2025.
  • GAMMA Investing's portfolio value rose 19% quarter-over-quarter to $1.58B.

Based on GAMMA Investing's 13F filing for Q2 2025, filed 14 Jul 2025.